Cargando…

Econometric modelling of multiple self-reports of health states: The switch from EQ-5D-3L to EQ-5D-5L in evaluating drug therapies for rheumatoid arthritis()

EQ-5D is used in cost-effectiveness studies underlying many important health policy decisions. It comprises a survey instrument describing health states across five domains, and a system of utility values for each state. The original 3-level version of EQ-5D is being replaced with a more sensitive 5...

Descripción completa

Detalles Bibliográficos
Autores principales: Hernández-Alava, Mónica, Pudney, Stephen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier North Holland 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5597047/
https://www.ncbi.nlm.nih.gov/pubmed/28778350
http://dx.doi.org/10.1016/j.jhealeco.2017.06.013
_version_ 1783263635966001152
author Hernández-Alava, Mónica
Pudney, Stephen
author_facet Hernández-Alava, Mónica
Pudney, Stephen
author_sort Hernández-Alava, Mónica
collection PubMed
description EQ-5D is used in cost-effectiveness studies underlying many important health policy decisions. It comprises a survey instrument describing health states across five domains, and a system of utility values for each state. The original 3-level version of EQ-5D is being replaced with a more sensitive 5-level version but the consequences of this change are uncertain. We develop a multi-equation ordinal response model incorporating a copula specification with normal mixture marginals to analyse joint responses to EQ-5D-3L and EQ-5D-5L in a survey of people with rheumatic disease, and use it to generate mappings between the alternative descriptive systems. We revisit a major cost-effectiveness study of drug therapies for rheumatoid arthritis, mapping the original EQ-5D-3L measure onto a 5L valuation basis. Working within a comprehensive, flexible econometric framework, we find that use of simpler restricted specifications can make very large changes to cost-effectiveness estimates with serious implications for decision-making.
format Online
Article
Text
id pubmed-5597047
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Elsevier North Holland
record_format MEDLINE/PubMed
spelling pubmed-55970472017-09-21 Econometric modelling of multiple self-reports of health states: The switch from EQ-5D-3L to EQ-5D-5L in evaluating drug therapies for rheumatoid arthritis() Hernández-Alava, Mónica Pudney, Stephen J Health Econ Article EQ-5D is used in cost-effectiveness studies underlying many important health policy decisions. It comprises a survey instrument describing health states across five domains, and a system of utility values for each state. The original 3-level version of EQ-5D is being replaced with a more sensitive 5-level version but the consequences of this change are uncertain. We develop a multi-equation ordinal response model incorporating a copula specification with normal mixture marginals to analyse joint responses to EQ-5D-3L and EQ-5D-5L in a survey of people with rheumatic disease, and use it to generate mappings between the alternative descriptive systems. We revisit a major cost-effectiveness study of drug therapies for rheumatoid arthritis, mapping the original EQ-5D-3L measure onto a 5L valuation basis. Working within a comprehensive, flexible econometric framework, we find that use of simpler restricted specifications can make very large changes to cost-effectiveness estimates with serious implications for decision-making. Elsevier North Holland 2017-09 /pmc/articles/PMC5597047/ /pubmed/28778350 http://dx.doi.org/10.1016/j.jhealeco.2017.06.013 Text en © 2017 The Authors http://creativecommons.org/licenses/by/4.0/ This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Hernández-Alava, Mónica
Pudney, Stephen
Econometric modelling of multiple self-reports of health states: The switch from EQ-5D-3L to EQ-5D-5L in evaluating drug therapies for rheumatoid arthritis()
title Econometric modelling of multiple self-reports of health states: The switch from EQ-5D-3L to EQ-5D-5L in evaluating drug therapies for rheumatoid arthritis()
title_full Econometric modelling of multiple self-reports of health states: The switch from EQ-5D-3L to EQ-5D-5L in evaluating drug therapies for rheumatoid arthritis()
title_fullStr Econometric modelling of multiple self-reports of health states: The switch from EQ-5D-3L to EQ-5D-5L in evaluating drug therapies for rheumatoid arthritis()
title_full_unstemmed Econometric modelling of multiple self-reports of health states: The switch from EQ-5D-3L to EQ-5D-5L in evaluating drug therapies for rheumatoid arthritis()
title_short Econometric modelling of multiple self-reports of health states: The switch from EQ-5D-3L to EQ-5D-5L in evaluating drug therapies for rheumatoid arthritis()
title_sort econometric modelling of multiple self-reports of health states: the switch from eq-5d-3l to eq-5d-5l in evaluating drug therapies for rheumatoid arthritis()
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5597047/
https://www.ncbi.nlm.nih.gov/pubmed/28778350
http://dx.doi.org/10.1016/j.jhealeco.2017.06.013
work_keys_str_mv AT hernandezalavamonica econometricmodellingofmultipleselfreportsofhealthstatestheswitchfromeq5d3ltoeq5d5linevaluatingdrugtherapiesforrheumatoidarthritis
AT pudneystephen econometricmodellingofmultipleselfreportsofhealthstatestheswitchfromeq5d3ltoeq5d5linevaluatingdrugtherapiesforrheumatoidarthritis